NewGenIvf (NIVF) Revenue (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Revenue of $1.4 million for Q4 2025, up 11.85% YoY from $1.3 million in Q4 2024, and up 11.1% sequentially from $1.3 million in Q3 2025.
NewGenIvf (NIVF) Revenue (2024 - 2025) Analysis & Trends
NewGenIvf has disclosed Revenue across 2 years of filings, most recently posting $1.4 million for Q4 2025.
- In Q4 2025, Revenue rose 11.85% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $5.5 million (changed N/A YoY), while the FY2025 annual figure was $4.7 million, down 13.01% from the prior year.
- Revenue grew to $1.4 million in Q4 2025, from $1.3 million in the prior quarter.
- Over the last five years, Revenue for NIVF reached as high as $1.5 million in Q3 2024 and fell as low as $1.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | 19.11 Bn |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | 657.51 Mn |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 5.37 Bn |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 3.42 Bn |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | 1.59 Bn |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 1.39 Bn |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 4.50 Bn |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | 1.42 Bn |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | -200.76 Mn |
| 10 | NewGenIvf | 25,304.95 | -1.41 Mn | 524,025.00 | 1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.47 Mn |